The Power of Antibody Profiling
Sengenics KREX® technology measures antibodies with industry-leading precision
Reveal targetable antigens | Unveil targetable or exploitable antibodies | Uncover disease mechanisms | Identify disease subtypes
Get your FREE white paper today!
Download this comprehensive white paper to:
Explore how anti-cytokine autoantibodies (ACAAs) affect immune regulation in health and disease
Understand the therapeutic potential of anti-cytokine antibodies in preclinical and clinical studies
Learn how Sengenics protein microarrays can support advancements in ACAA research
"*" indicates required fields
Sengenics KREX® technology measures antibodies with industry-leading precision
Reveal targetable antigens | Unveil targetable or exploitable antibodies | Uncover disease mechanisms | Identify disease subtypes
Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.
© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D
Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap
Design and development by RainCastle Communications.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields